This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

CME Academic Highlights

Benzodiazepines: Revisiting Clinical Issues in Treating Anxiety Disorders

by Jerrold F. Rosenbaum, MD; Charles P. O†Brien, MD, PhD; Michael W. Otto, PhD; Mark H. Pollack, MD; Peter P. Roy-Byrne, MD; Samantha A. Stewart, MD

Published: February 15, 2005

Article Abstract

Click to enlarge page

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Chair Jerrold F. Rosenbaum, M.D., began the meeting by explaining that he had been asked to be a discussant at a case conference at Massachusetts General Hospital where Samantha A. Stewart, M.D., presented the case of a woman (described herein by Dr. Stewart) who was admitted with cognitive deficits potentially caused by benzodiazepine abuse and dependence–issues that were heavily debated during the 1980s. Dr. Rosenbaum stated that the purpose of the meeting was to address concerns related to benzodiazepine use in clinical practice today.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 7

Quick Links: Anxiety

References

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Clinical and Practical Psychopharmacology

Antipsychotic Augmentation With N-Acetylcysteine for Patients With Schizophrenia

Dr Andrade discusses whether or not recent findings support the use of NAC as antipsychotic augmentation in...

Read More...